State Alcohol and Drug Policy Commission recommended allocation, which OHA will administer
PORTLAND, Ore. – A $13.08 million allocation by the Opioid Settlement Prevention, Treatment & Recovery Board (Settlement Board) will expand and strengthen the state’s access to substance use disorder treatment and services through opioid treatment programs (OTPs) and jails.
The Board approved Alcohol and Drug Policy Commission (ADPC) recommendations July 10. The allocation, which Oregon Health Authority (OHA) will administer, will improve access to medication for opioid use disorder and treatment services by providing:
- Up to $3.9 million to fund:
- Two mobile or non-mobile medication units in Clackamas County serving Oregon City and rural Clackamas County.
- An opioid treatment program or a mobile or non-mobile medication unit in Multnomah County serving the geographic areas of the county with the highest unmet need.
- Up to $9.1 million to fund a total of seven opioid treatment programs or mobile or non-mobile medication units, specifically:
- Two in Northeastern Oregon.
- One in the Mid-Gorge region.
- One in Klamath County.
- Two in underserved coastal areas.
- One in eastern Lane County.
To be eligible for funding, a mobile or non-mobile medication unit or an opioid treatment program must be currently certified by OHA.
- Up to $250,000 to Oregon Health & Science University (OHSU) to provide technical assistance to jails and to foster collaboration between opioid treatment providers and jails.
The funding was awarded to OHA, which will administer the allocations. The Board’s decision can be viewed in a recording of its July 10 meeting here.
Prior to awarding any funding, OHA must engage the partners listed in the ADPC proposal and provide a proposed timeline and implementation plan to the Board for approval no later than Sept. 1, 2024.
Since July 2021, the State of Oregon has reached agreement on national lawsuits against several companies for their role in the opioid crisis. Through these agreements, nearly $600 million will be awarded to Oregon over the course of 18 years. Settlement funds from opioid manufacturers, distributors and pharmacies are divided between the State of Oregon (45%) and local jurisdictions (55%).
The state’s share is deposited as it becomes available into the Opioid Settlement, Prevention, Treatment and Recovery (OSPTR) Fund. This fund is controlled by the 18-member OSPTR Board.
Local jurisdictions receiving settlement funds (those with populations greater than 10,000) decide how their funds are used. Cities and counties are required to report to the Oregon Department of Justice annually on how they have allocated their funds.
For state and local spending details from Fiscal Year 2022-2023, refer to the Oregon Opioid Settlement Spending Report: https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/SUBSTANCEUSE/OPIOIDS/Documents/opioid-settlement-report-fy-22-23.pdf.
The OSPTR Board will next consider additional investments in emerging issues.
To learn more about Oregon’s opioid settlement funds, visit oregon.gov/opioidsettlement.
###
